Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05506085
Other study ID # 14578
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date October 1, 2022
Est. completion date May 1, 2025

Study information

Verified date June 2024
Source Indiana University
Contact Rita Patel, PhD
Phone 8128553886
Email patelrir@iu.edu
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Deep Brain Stimulation (DBS) is a neurosurgical procedure used to treat tremors, and dystonia. This study will enroll people who have a form of focal dystonia that affects their vocal cords called Adductor Laryngeal dystonia (ADLD). Participants will undergo Deep Brain Stimulation surgery to treat laryngeal dystonia as part of their clinical care. Before surgery, as part of the study they will have specialized testing to study the movement of the vocal cords, as well as functional magnetic resonance imaging (fMRI). While in the operating room, researchers will examine brain waves to better understand how faulty brain firing patterns lead to dystonia. After surgery, and activation of the deep brain stimulator, participants will repeat speech testing and vocal cord imaging as well as magnetic resonance imaging (MRI).


Recruitment information / eligibility

Status Recruiting
Enrollment 12
Est. completion date May 1, 2025
Est. primary completion date May 1, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: - Patients with ADLD and ADLD plus tremor, as diagnosed by routine clinical examination by laryngologist, speech language pathologist, and neurologist. - Patients undergoing globus pallidus interna (GPi) deep brain stimulation (DBS) for ADLD with tremor - Age range of 18-80 years - Native speakers of American English will be recruited since there are known differences in voice and neural signals of native and non-native speakers - No evidence for dementia as assessed by neurologist. - No evidence for severe untreated mood disorder as assessed by neurologist, or as evident on self-report (Beck Depression Inventory-II score > 29, Beck Anxiety Inventory Score > 26. - At least 3 months since last botulinum toxin injection and the patients would need to be fully symptomatic with no residual effects of botulinum toxin on voice quality. Exclusion Criteria: - Individuals younger than 18 years and older than 80 years of age. - Women who plan to become pregnant during the study period or are currently breastfeeding. - Prior history of stroke, brain surgery, or other neurological disorder besides the one under study. - Prior laryngeal framework surgeries or other disorders affecting the vocal folds - Patients who are asymptomatic due to treatment with botulinum toxin into the vocal folds. - Presence of ferromagnetic implants and cardiac implants that would be contraindicated to MRI - Gagging or discomfort that would preclude the placement of the endoscope to visualize the larynx - Dementia, severe depression or severe anxiety. - Any clinical condition or medication judged by the investigators to potentially preclude the patient from safely completing awake brain surgery and research protocols.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Deep Brain Stimulation
Deep Brain Stimulation of Globus Pallidus interna

Locations

Country Name City State
United States Indiana University Indianapolis Indiana

Sponsors (2)

Lead Sponsor Collaborator
Indiana University National Institutes of Health (NIH)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in total number of Vocal fold movements Vocal fold movements will be quantified (vibratory breaks + micromotions+ aperiodicities) using high-speed videoendoscopy (HSV) on sustained phonation of the vowel, words, and sentence production. The videoendoscopic recording will be obtained Before surgery, within 24 hours after surgery, 6 -9 months after surgery
Primary Change in Acoustic voice recordings Acoustic voice recordings will be obtained using a microphone. Acoustic measurement of voice (voicing percentage) will be obtained from sustained phonation of the vowel /a/, sentences and reading a paragraph. Before surgery, within 24 hours after surgery, 6-9 months after surgery
Primary Microelectrode recording Microelectrode recording is performed routinely during DBS (Deep brain stimulation) surgery. The study procedure will be to record voice simultaneously on sustained phonation of the vowels, syllables, and sentences using the data acquisition system NI USM 6221 with a microphone and high-speed videoendoscopy. Beta and theta band power spectral density will be analyzed as measurements. during surgery
Secondary Change in Neuropsychological testing: Trails A Neuropsychological testing will be obtained pre (standard of care for DBS surgery) and 6 months post DBS surgery (experimental) to evaluate psychomotor speed Before surgery, and 6-9 months after surgery
Secondary Change in Neuropsychological testin: Trails B Neuropsychological testing will be obtained pre (standard of care for DBS surgery) and 6 months post DBS surgery (experimental) to evaluate mental flexibility Before surgery, and 6-9 months after surgery
Secondary Change in Neuropsychological testing: Controlled Oral Word Association Animal fluency Neuropsychological testing will be obtained pre (standard of care for DBS surgery) and 6-9 months post DBS surgery (experimental) to evaluate verbal fluency Before surgery, and 6-9 months after surgery
Secondary Change in Resting state Functional Magnetic Resonance Imaging (fMRI) Resting state Functional Magnetic Resonance Imaging (rs-FMRI) before surgery and 6-9 months after surgery
Secondary Change in Voice Handicap Index A 30-point questionnaire to describe the voice and the effects of voice on their daily lives. The scores range from 0 to 120. 0 to 30 is a low score with minimal handicap and 61 to 120 is considered severe handicap, 31 to 60 moderate handicap before surgery and 6-9 months after surgery
Secondary Change in Speech Intelligibility will be computed from the 2nd, 3rd, and 4th sentences of the Rainbow passage as the number of correct words identified. before surgery and 6-9 months after surgery
See also
  Status Clinical Trial Phase
Recruiting NCT06111027 - Usability of Vibro-tactile Stimulation to Treat Spasmodic Dysphonia Phase 1/Phase 2
Withdrawn NCT02061943 - Examining the Spasmodic Dysphonia Diagnosis and Assessment Procedure (SD-DAP) for Measuring Symptom Change N/A
Recruiting NCT05580302 - Cortical Silent Period in Laryngeal Dystonia
Recruiting NCT05150106 - Characterization of Clinical Phenotypes of Laryngeal Dystonia and Voice Tremor
Recruiting NCT05110417 - Reversal of Botulinum Neurotoxin Injection Related Dysphonia With Pyridostigmine Phase 4
Recruiting NCT05216770 - Understanding Disorder-specific Neural Pathophysiology in Laryngeal Dystonia and Voice Tremor Early Phase 1
Recruiting NCT05150093 - Deep Brain Stimulation in Laryngeal Dystonia and Voice Tremor N/A
Recruiting NCT05095740 - Effects of Neuromodulation in Laryngeal Dystonia N/A
Recruiting NCT03042975 - Imaging Genetics of Laryngeal Dystonia
Completed NCT02957942 - rTMS in Spasmodic Dysphonia N/A
Completed NCT02558634 - Thalamic Deep Brain Stimulation for Spasmodic Dysphonia- DEBUSSY Trial N/A
Not yet recruiting NCT05467228 - Laryngeal Vibro-tactile Stimulation as a Non-invasive Symptomatic Treatment for Spasmodic Dysphonia Phase 2
Recruiting NCT05245942 - Monitoring of the Safety and the Performance of the Endoscopic Cap Electrode (ECE50)
Recruiting NCT04421365 - Brain-Computer Interfaces in Laryngeal Dystonia N/A